When Dr. Yezaz Ghouri sees patients with the cramping, abdominal pain and diarrhea that are hallmark symptoms of irritable bowel syndrome (IBS), he’ll typically ask how life’s going. More often than not, his patients say they are experiencing stress in their lives. Now, Ghouri’s team has established a link between IBS and anxiety, depression and…  read on >  read on >

While adult bed rails are marketed with safety in mind, they need to be used with caution, the U.S. Food and Drug Administration advises. “Many death and injury reports related to entrapment and falls for adult portable bed rail products and hospital bed rails have been reported to the FDA and the CPSC [U.S. Consumer…  read on >  read on >

WEDNESDAY, March 1, 2023 (American Heart Association News) — Members of Black churches in New Orleans who believe religion plays an important role in their health may be more likely to eat fruits and vegetables, be physically active and have confidence asking questions of health care providers than their peers who don’t share that belief,…  read on >  read on >

When former President Jimmy Carter recently entered home hospice care after many years of cancer treatment, it was an invitation for families across America to consider how they would like to spend their final days. For experts in end-of-life care, the 98-year-old’s announcement was one last act of public service. “Hospice is often an incredible…  read on >  read on >

After a heart attack, home rehab can literally be a lifesaver, a new study finds. Taking part in a home-based cardiac rehabilitation program lowered the risk of dying from heart complications by 36% within four years, compared with patients who were not in a rehab program, researchers report. “Cardiac rehabilitation programs save lives,” said lead…  read on >  read on >

In a tight vote, U.S. Food and Drug Administration advisors on Tuesday recommended the approval of an RSV vaccine that could be used in Americans ages 60 and up. The vaccine, known as RENOIR, was developed by pharmaceutical giant Pfizer Inc. The same panel of advisors will weigh the potential approval of another respiratory syncytial…  read on >  read on >